Showing 8241-8250 of 8647 results for "".
- Heidelberg Engineering Introduces the GMPE Hood Glaucoma Report for Spectralis OCThttps://modernod.com/news/heidelberg-engineering-introduces-the-gmpe-hood-glaucoma-report-for-spectralis-oct/2479582/Heidelberg Engineering announced that the Hood Glaucoma Report is now available with a software update within the Spectralis OCT Glaucoma Module Premium Edition (GMPE). The GMPE Hood Glaucoma Report highlights
- First Subjects Enrolled in Clinical Study to Evaluate Safety and Efficacy of OMNI Surgical System for MIGS Procedureshttps://modernod.com/news/first-subjects-enrolled-in-clinical-study-to-evaluate-safety-and-efficacy-of-omni-surgical-system-for-migs-procedures/2476422/Sight Sciences announced that enrollment has begun in the Gemini clinical study, a Sight Sciences-sponsored, prospective, multicenter study to evaluate the safety and efficacy of the OMNI Surgical System in performing two sequential micro-invasive glaucoma surgery (MIGS) procedures—transluminal v
- Topcon Unveils New Maestro Unlimited OCT System at VEE 2019https://modernod.com/news/topcon-to-present-new-solution-for-oct-and-data-management-at-vee-2019/2476407/Topcon showcased several innovative new offerings at the Vision Expo East (VEE) conference in New York City. Topcon unveiled the new Maestro Unlimited, which pairs the Maestro 3D OCT with the new Topcon Harmony, a web-based data management application that provides unlimited device connect
- Study: Excess Hormones Could Cause a Condition That Can Lead to Blindness in Womenhttps://modernod.com/news/study-excess-hormones-could-cause-a-condition-that-can-lead-to-blindness-in-women/2476403/Research led by the University of Birmingham, UK, has found that increased levels of hormones including testosterone could cause a brain condition that can lead to blindness in women. Idiopathic Intracranial Hypertension—also known as IIH—is caused by high pressure in the brain with conseq
- Compulink Previews New User Interface for its Optometry SMART EHR at Vision Expo Easthttps://modernod.com/news/compulink-previews-new-user-interface-for-its-optometry-smart-ehr-at-vision-expo-east/2476404/Compulink Healthcare Solutions, the creator of Advantage SMART Practice, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), previewed the new user interface for its Eyecare Advantage at Vision Expo this week. Designed by a team of usability experts,
- VSP Global Names Steve Baker President of VSP Ventureshttps://modernod.com/news/vsp-global-names-steve-baker-president-of-vsp-ventures/2476398/VSP Global has announced the appointment of Steve Baker, president of Eyefinity, to lead the newly-established VSP Ventures, according to a report in VisionMonday. “Steve’
- 5% People Tested Positive at Free Initial Screenings for Glaucoma at Saifee Hospitalhttps://modernod.com/news/5-people-tested-positive-at-free-initial-screenings-for-glaucoma-at-saifee-hospital/2476400/Saifee Hospital, one of Mumbai’s leading multi-specialty hospitals, conducted almost 400 free eye check-ups for their visitors to observe World Glaucoma Week. The check-ups were conducted throughout the week and more than 20 people were detected to have high
- Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kithttps://modernod.com/news/q-biomed-and-mannin-research-to-develop-gdf15-biomarker-glaucoma-diagnostic-kit/2476396/Q BioMed announced that its technology partner Mannin Research has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression. This enabling te
- Lilliana Vazquez to Moderate Vision Expo’s EYE2EYE Series with Commonhttps://modernod.com/news/lilliana-vazquez-to-moderate-vision-expos-eye2eye-series-with-common/2476392/Vision Expo has announced Lilliana Vazquez will moderate its inaugural EYE2EYE series with award-winning artist Common. Ms. Vazquez is a multi-media personality that has acted as a host, influencer, style advisor and producer for the biggest names in entertainment, including working as a contribu
- Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitishttps://modernod.com/news/nicox-initiates-phase-2-trial-of-ncx-4251-in-blepharitis/2476393/Nicox SA announced the initiation of a phase 2 clinical trial evaluating NCX 4251, its novel patented ophthalmic suspension of fluticasone propionate nanocrystals, being developed as the first targeted topical treatm